Active Ingredient History

  • Now
Daclizumab is a therapeutic humanized monoclonal antibody which was used for the treatment of adults with relapsing forms of multiple sclerosis (MS). Daclizumab works by binding to CD25, the alpha subunit of the IL-2 receptor of T-cells.   Wikipedia

More Chemistry
anti-il-2r | anti-il2r ab | dacliximab | daclizumab | daclizumab beta | dalclizumab | immunoglobulin g 1, (human-mouse monoclonal 1h4 gamma-chain, anti-human interleukin 2 receptor), disulfide with human-mouse monoclonal clone 1h4 light chain, dimer | ro 24-7375 | ro-24-7375 | zenapax | zinbryta


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue